Literature DB >> 9029743

Population pharmacokinetics of felbamate in children.

M T Kelley1, P D Walson, S Cox, L J Dusci.   

Abstract

Information about the pharmacokinetics of felbamate in children is limited. Even though it is claimed that monitoring of felbamate concentrations is unnecessary, many neurologists have requested therapeutic drug monitoring (TDM) for various reasons. This study used the NONMEM program to describe the pharmacokinetics and the influence of other anticonvulsants on the pharmacokinetics of felbamate. Felbamate, carbamazepine (CBZ), phenytoin (PHY), valproate (VPA), and barbiturate serum levels were obtained by our TDM service as requested by the clinician. The clearance and volume of distribution of felbamate were 41.1 ml/h/kg and 908 ml/kg, respectively. CBZ and PHY increased the clearance 49 and 40% while VPA decreased it 21%. Barbiturate had no significant effect. Clearance also decreased with age.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029743     DOI: 10.1097/00007691-199702000-00005

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  6 in total

1.  Rapid and sensitive LC-MS/MS method for determination of felbamate in mouse plasma and tissues and human plasma.

Authors:  Ryan J Hansen; Bradley J Samber; Daniel L Gustafson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-10-16       Impact factor: 3.205

Review 2.  Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age.

Authors:  Emilio Perucca
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 3.  Use of second-generation antiepileptic drugs in the pediatric population.

Authors:  Allison M Chung; Lea S Eiland
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 4.  Pharmacokinetics and Drug Interaction of Antiepileptic Drugs in Children and Adolescents.

Authors:  Giulia Iapadre; Ganna Balagura; Luca Zagaroli; Pasquale Striano; Alberto Verrotti
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

Review 5.  Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.

Authors:  Philip N Patsalos
Journal:  Clin Pharmacokinet       Date:  2013-11       Impact factor: 6.447

Review 6.  An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs.

Authors:  Shery Jacob; Anroop B Nair
Journal:  Drugs R D       Date:  2016-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.